Découvrez le nouveau Chem-Impex : là où l'innovation commence par une liaison.

Catalog Number:
42174
CAS Number:
194423-06-8
CL-387785
Purity:
≥ 98% (CG)
Synonym(s):
N- [4-[(3-bromophényl)amino]-6-quinazolinyl)-2-butynamide
Documents
$168.35 /25 mg
Taille
Request Bulk Quote
Informations sur le produit

CL-387785 is a potent compound recognized for its unique structure and significant potential in pharmaceutical research. This compound, also known as N-[4-(3-bromoanilino)quinazolin-6-yl]but-2-ynamide, has garnered attention for its application in the development of targeted therapies, particularly in oncology. Its distinctive quinazoline framework allows for selective inhibition of specific kinases, making it a valuable candidate for studies focused on cancer treatment and other diseases characterized by aberrant signaling pathways. Researchers have noted its effectiveness in preclinical models, showcasing its ability to impede tumor growth and enhance the efficacy of existing therapies.

The compound's versatility extends beyond oncology, with potential applications in various therapeutic areas, including inflammation and autoimmune disorders. Its favorable pharmacokinetic properties, such as solubility and bioavailability, further enhance its appeal for drug development. As the pharmaceutical industry continues to seek innovative solutions, CL-387785 stands out as a promising lead compound, offering researchers a powerful tool for advancing therapeutic strategies.

Numéro CAS 
194423-06-8
Formule moléculaire
C 18 H 13 BrN 4 O
Poids moléculaire 
381.23
Point de fusion 
276 °C (lit.)
Informations générales
Numéro CAS 
194423-06-8
Formule moléculaire
C 18 H 13 BrN 4 O
Poids moléculaire 
381.23
Point de fusion 
276 °C (lit.)
Propriétés
Informations complémentaires sur la propriété à venir prochainement !
-
Sécurité et réglementation
Matières dangereuses
-
Antibiotique
-
Réglementé par la DEA
Non
Avertissements 
-
Applications

CL-387785 is widely utilized in research focused on:

  • Cancer Research: This compound has shown promise in inhibiting specific cancer cell lines, making it a valuable tool for researchers developing targeted therapies.
  • Drug Development: Its unique structure allows scientists to explore new pathways for drug design, particularly in the development of kinase inhibitors.
  • Biochemical Assays: CL-387785 can be used in various assays to study protein interactions, helping researchers understand disease mechanisms at a molecular level.
  • Pharmaceutical Formulations: The compound's stability and efficacy make it suitable for incorporation into formulations aimed at treating specific types of tumors.
  • Targeted Therapy Research: Its specificity in targeting certain cellular pathways positions it as a key candidate in the exploration of personalized medicine approaches.

Citations